MA53225A - Agents inhibiteurs d'ask1 - Google Patents

Agents inhibiteurs d'ask1

Info

Publication number
MA53225A
MA53225A MA053225A MA53225A MA53225A MA 53225 A MA53225 A MA 53225A MA 053225 A MA053225 A MA 053225A MA 53225 A MA53225 A MA 53225A MA 53225 A MA53225 A MA 53225A
Authority
MA
Morocco
Prior art keywords
inhibiting agents
ask1
ask1 inhibiting
agents
inhibiting
Prior art date
Application number
MA053225A
Other languages
English (en)
Inventor
Lopez De Turiso Felix Gonzalez
Martin Himmelbauer
John H Jones
Zhili Xin
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of MA53225A publication Critical patent/MA53225A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA053225A 2018-08-14 2019-08-13 Agents inhibiteurs d'ask1 MA53225A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862718622P 2018-08-14 2018-08-14

Publications (1)

Publication Number Publication Date
MA53225A true MA53225A (fr) 2021-06-23

Family

ID=67777431

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053225A MA53225A (fr) 2018-08-14 2019-08-13 Agents inhibiteurs d'ask1

Country Status (12)

Country Link
US (1) US11999715B2 (fr)
EP (1) EP3837251B1 (fr)
JP (1) JP2021534152A (fr)
CN (1) CN113227070A (fr)
AU (1) AU2019321412A1 (fr)
BR (1) BR112021002690A2 (fr)
CA (1) CA3109504A1 (fr)
CO (1) CO2021003218A2 (fr)
ES (1) ES2963122T3 (fr)
MA (1) MA53225A (fr)
MX (1) MX2021001783A (fr)
WO (1) WO2020036949A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114907358A (zh) * 2021-02-09 2022-08-16 上海翰森生物医药科技有限公司 含吡啶多环类衍生物调节剂、其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
WO2005040152A1 (fr) * 2003-10-20 2005-05-06 E.I. Dupont De Nemours And Company Azolecarboxamides substitues par heterocyclylphenyle et heterocyclylpyridile
US7756674B2 (en) * 2007-08-03 2010-07-13 The Trustees Of Columbia University In The City Of New York Methods of calculating differences of binding affinities between congeneric pairs of ligands by way of a displaced solvent functional
EP2271646A1 (fr) * 2008-03-31 2011-01-12 Takeda Pharmaceutical Company Limited Inhibiteurs de kinase 1 de régulation de signal d'apoptose
WO2010008843A1 (fr) * 2008-06-24 2010-01-21 Takeda Pharmaceutical Company Limited Inhibiteurs de kinases 1 régulant le signal apoptotique
MX2011003292A (es) * 2008-09-29 2011-04-21 Boehringer Ingelheim Int Compuestos antiproliferativos.
TWI598347B (zh) * 2009-07-13 2017-09-11 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
WO2011041293A1 (fr) * 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Dérivés pyrazolo [1, 5—a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose
SI2531501T1 (sl) * 2010-02-03 2014-04-30 Takeda Pharmaceutical Company Limited Inhibitorji kinaze-1, ki regulirajo signal apoptoze
MX2012015105A (es) * 2010-07-02 2013-05-28 Gilead Sciences Inc Inhibidores de cinasa de regulacion mediante señal de apoptosis.
CN114907358A (zh) * 2021-02-09 2022-08-16 上海翰森生物医药科技有限公司 含吡啶多环类衍生物调节剂、其制备方法和应用

Also Published As

Publication number Publication date
ES2963122T3 (es) 2024-03-25
MX2021001783A (es) 2021-08-11
EP3837251B1 (fr) 2023-06-21
WO2020036949A8 (fr) 2020-09-10
WO2020036949A1 (fr) 2020-02-20
AU2019321412A1 (en) 2021-03-04
CO2021003218A2 (es) 2021-03-29
US11999715B2 (en) 2024-06-04
BR112021002690A2 (pt) 2021-05-11
CN113227070A (zh) 2021-08-06
EP3837251A1 (fr) 2021-06-23
CA3109504A1 (fr) 2020-02-20
US20210317103A1 (en) 2021-10-14
JP2021534152A (ja) 2021-12-09

Similar Documents

Publication Publication Date Title
EP3735685A4 (fr) Panneau d'affichage
EP3750149C0 (fr) Panneau d'affichage
EP3906029A4 (fr) Inhibiteurs de l'interaction ménine-mll
MA44725A (fr) Formulations d'un inhibiteur de lsd1
EP3798719A4 (fr) Panneau d'affichage
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
MA49006A (fr) Inhibiteurs d'ip6k
MA54521A (fr) Dérivés d'oxopyridine substitués
EP3820980A4 (fr) Compositions d'esterquats
MA53648A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase
EP3598705A4 (fr) Commande d'acheminement
EP3808747A4 (fr) Composé d'imidazopyridinone
EP3496882A4 (fr) Plaque d'amortissement
EP3815846A4 (fr) Machine d'entraînement
EP3761922C0 (fr) Support d'épaule orthétique
EP3794015A4 (fr) Agents d'activation
MA43764A (fr) Inhibiteur monovalent de l'interaction hutnfr1
EP3760380A4 (fr) Machine d'entraînement
EP3811606A4 (fr) Kit d'urgence
EP3809062A4 (fr) Vanne d'arrêt
EP3819231C0 (fr) Récipient d'application
EP3742509A4 (fr) Panneau d'affichage
MA53009A (fr) Agents inhibiteurs d'ask1
EP3773577A4 (fr) Inhibiteurs d'ask1 tricycliques
MA53225A (fr) Agents inhibiteurs d'ask1